Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...
Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...
At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...
Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...
Williams, A. and Louis, L. (2026) Cumulative Link Modeling of Ordinal Outcomes in the National Health Interview Survey Data: Application to Depressive Symptom Severity. Journal of Data Analysis and ...
Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and survival in SOD1-ALSOver ...
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a ...
FC Porto issued a statement following the controversial refereeing in the Santa Clara vs. Sporting match. “After another week marked by controversy and incomprehensible decisions that compromise the ...
From staffing decisions to growth strategy, these are the changes ASC leaders said they would make if given a do-over for 2025. Question: Looking back at the past year, what’s one thing you would do ...
(CNN) - The Food and Drug Administration is looking into whether deaths across multiple age groups are related to COVID-19 vaccines. The announcement on Tuesday follows a November memo from a FDA ...